4DMedical Issues New Shares Under Long-Term Incentive Plan, Confirms Regulatory Compliance

4DMedical Ltd ( (AU:4DX) ) has shared an announcement.

4DMedical Limited has issued 162,045 fully paid ordinary shares following the exercise of options under its Long Term Incentive Plan, expanding its share capital without a formal prospectus disclosure. The company confirmed it is compliant with key financial reporting and continuous disclosure obligations under the Corporations Act and stated there is no undisclosed price-sensitive information of the type that would require additional market notification.

The issuance under the cleansing notice mechanism ensures the new shares can be traded on-market without further disclosure, supporting liquidity for participating employees and aligning management and staff with shareholder interests. This move underscores 4DMedical’s adherence to regulatory requirements as it continues to develop and commercialise its respiratory imaging technologies in global healthcare markets.

The most recent analyst rating on (AU:4DX) stock is a Sell with a A$3.00 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.

More about 4DMedical Ltd

4DMedical Limited is a global medical technology company focused on revolutionising respiratory care through advanced imaging and artificial intelligence. Its patented XV Technology turns standard lung scans into detailed functional insights, supporting earlier and more precise detection, diagnosis, and monitoring of lung disease for hospitals and clinicians worldwide.

The company’s software portfolio includes FDA-cleared XV Lung Ventilation Analysis Software, CT LVAS, and the CT:VQ solution, which combines ventilation and perfusion analysis to set new standards in cardiothoracic imaging. Delivered via a SaaS model that integrates with existing hospital systems and enhanced by AI capabilities from its 2023 Imbio acquisition, 4DMedical aims to improve physician productivity and enable more personalised patient care globally.

Average Trading Volume: 7,474,827

Technical Sentiment Signal: Buy

Current Market Cap: A$3.73B

For detailed information about 4DX stock, go to TipRanks’ Stock Analysis page.